S&P 500   4,328.04 (-0.05%)
DOW   34,016.65 (-0.16%)
QQQ   358.27 (+0.11%)
AAPL   175.04 (+0.64%)
MSFT   317.37 (-0.68%)
META   300.03 (+1.45%)
GOOGL   130.37 (-0.05%)
AMZN   129.07 (-0.20%)
TSLA   247.37 (-3.26%)
NVDA   414.88 (+1.15%)
NIO   8.48 (+0.36%)
BABA   88.29 (+4.97%)
AMD   96.19 (+0.08%)
T   15.19 (-0.78%)
F   12.48 (+2.30%)
MU   69.00 (+1.62%)
CGC   0.81 (+5.84%)
GE   111.73 (-1.12%)
DIS   81.47 (-1.52%)
AMC   7.72 (+0.26%)
PFE   32.58 (-0.82%)
PYPL   57.95 (-1.14%)
NFLX   379.13 (-1.31%)
S&P 500   4,328.04 (-0.05%)
DOW   34,016.65 (-0.16%)
QQQ   358.27 (+0.11%)
AAPL   175.04 (+0.64%)
MSFT   317.37 (-0.68%)
META   300.03 (+1.45%)
GOOGL   130.37 (-0.05%)
AMZN   129.07 (-0.20%)
TSLA   247.37 (-3.26%)
NVDA   414.88 (+1.15%)
NIO   8.48 (+0.36%)
BABA   88.29 (+4.97%)
AMD   96.19 (+0.08%)
T   15.19 (-0.78%)
F   12.48 (+2.30%)
MU   69.00 (+1.62%)
CGC   0.81 (+5.84%)
GE   111.73 (-1.12%)
DIS   81.47 (-1.52%)
AMC   7.72 (+0.26%)
PFE   32.58 (-0.82%)
PYPL   57.95 (-1.14%)
NFLX   379.13 (-1.31%)
S&P 500   4,328.04 (-0.05%)
DOW   34,016.65 (-0.16%)
QQQ   358.27 (+0.11%)
AAPL   175.04 (+0.64%)
MSFT   317.37 (-0.68%)
META   300.03 (+1.45%)
GOOGL   130.37 (-0.05%)
AMZN   129.07 (-0.20%)
TSLA   247.37 (-3.26%)
NVDA   414.88 (+1.15%)
NIO   8.48 (+0.36%)
BABA   88.29 (+4.97%)
AMD   96.19 (+0.08%)
T   15.19 (-0.78%)
F   12.48 (+2.30%)
MU   69.00 (+1.62%)
CGC   0.81 (+5.84%)
GE   111.73 (-1.12%)
DIS   81.47 (-1.52%)
AMC   7.72 (+0.26%)
PFE   32.58 (-0.82%)
PYPL   57.95 (-1.14%)
NFLX   379.13 (-1.31%)
S&P 500   4,328.04 (-0.05%)
DOW   34,016.65 (-0.16%)
QQQ   358.27 (+0.11%)
AAPL   175.04 (+0.64%)
MSFT   317.37 (-0.68%)
META   300.03 (+1.45%)
GOOGL   130.37 (-0.05%)
AMZN   129.07 (-0.20%)
TSLA   247.37 (-3.26%)
NVDA   414.88 (+1.15%)
NIO   8.48 (+0.36%)
BABA   88.29 (+4.97%)
AMD   96.19 (+0.08%)
T   15.19 (-0.78%)
F   12.48 (+2.30%)
MU   69.00 (+1.62%)
CGC   0.81 (+5.84%)
GE   111.73 (-1.12%)
DIS   81.47 (-1.52%)
AMC   7.72 (+0.26%)
PFE   32.58 (-0.82%)
PYPL   57.95 (-1.14%)
NFLX   379.13 (-1.31%)
NYSE:EQC

Equity Commonwealth (EQC) Stock Forecast, Price & News

$18.50
+0.03 (+0.16%)
(As of 02:39 PM ET)
Compare
Today's Range
$18.37
$18.54
50-Day Range
$18.47
$20.60
52-Week Range
$18.37
$27.39
Volume
626,027 shs
Average Volume
1.04 million shs
Market Capitalization
$2.03 billion
P/E Ratio
32.46
Dividend Yield
N/A
Price Target
N/A

Equity Commonwealth MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.62% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.36mentions of Equity Commonwealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$963,000 Sold Last Quarter
Proj. Earnings Growth
-10.71%
From $0.84 to $0.75 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Finance Sector

569th out of 814 stocks

Real Estate Investment Trusts Industry

120th out of 173 stocks


EQC stock logo

About Equity Commonwealth (NYSE:EQC) Stock

Equity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC's portfolio is comprised of four properties totaling 1.5 million square feet.

EQC Price History

EQC Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Q2 2023 Equity Commonwealth Earnings Call
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Equity Commonwealth (NYSE: EQC)
EQC.PD Equity Commonwealth 6.5% CNV PFD D
EQC - Equity Commonwealth
Q1 2023 Equity Commonwealth Earnings Call
Equity Commonwealth 6.5% Cum. Conv. Pfd. Series D
See More Headlines
Receive EQC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Equity Commonwealth and its competitors with MarketBeat's FREE daily newsletter.

EQC Company Calendar

Last Earnings
10/27/2021
Today
9/22/2023
Next Earnings (Estimated)
10/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Office REITs
Sector
Finance
CUSIP
20323310
Employees
22
Year Founded
N/A

Profitability

Net Income
$37.26 million
Pretax Margin
121.17%

Debt

Sales & Book Value

Annual Sales
$63.14 million
Cash Flow
$0.50 per share
Book Value
$24.72 per share

Miscellaneous

Free Float
106,658,000
Market Cap
$2.03 billion
Optionable
Optionable
Beta
0.29
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. David A. Helfand (Age 58)
    Pres, CEO & Chairman
    Comp: $2.45M
  • Mr. William H. Griffiths (Age 50)
    Exec. VP, CFO & Treasurer
    Comp: $1.16M
  • Mr. David S. Weinberg (Age 54)
    Exec. VP & COO
    Comp: $1.49M
  • Mr. Orrin S. Shifrin (Age 56)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $1.32M
  • Mr. Andrew Levy
    Sr. VP & Chief Accounting Officer













EQC Stock - Frequently Asked Questions

How have EQC shares performed in 2023?

Equity Commonwealth's stock was trading at $24.97 on January 1st, 2023. Since then, EQC shares have decreased by 25.8% and is now trading at $18.52.
View the best growth stocks for 2023 here
.

Are investors shorting Equity Commonwealth?

Equity Commonwealth saw a decrease in short interest in August. As of August 15th, there was short interest totaling 1,820,000 shares, a decrease of 18.0% from the July 31st total of 2,220,000 shares. Based on an average daily trading volume, of 913,400 shares, the short-interest ratio is currently 2.0 days. Approximately 1.7% of the company's stock are sold short.
View Equity Commonwealth's Short Interest
.

When is Equity Commonwealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023.
View our EQC earnings forecast
.

How were Equity Commonwealth's earnings last quarter?

Equity Commonwealth (NYSE:EQC) issued its quarterly earnings results on Wednesday, October, 27th. The real estate investment trust reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. The real estate investment trust earned $13.88 million during the quarter, compared to the consensus estimate of $14.47 million. Equity Commonwealth had a net margin of 117.12% and a trailing twelve-month return on equity of 2.88%. The business's revenue was down 15.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.03 EPS.

How often does Equity Commonwealth pay dividends? What is the dividend yield for Equity Commonwealth?

Equity Commonwealth declared a dividend on Sunday, February 19th. Investors of record on Thursday, February 23rd will be paid a dividend of $4.25 per share on Thursday, March 9th. This represents a dividend yield of 20.22%. The ex-dividend date of this dividend is Wednesday, February 22nd. This is a positive change from the stock's previous dividend of $1.00.
Read our dividend analysis for EQC
.

What other stocks do shareholders of Equity Commonwealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Equity Commonwealth investors own include Portola Pharmaceuticals (PTLA), Dicerna Pharmaceuticals (DRNA), Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), Berkshire Hathaway (BRK.B), eBay (EBAY), Energy Transfer (ET), Alphabet (GOOG) and Skyworks Solutions (SWKS).

What is Equity Commonwealth's stock symbol?

Equity Commonwealth trades on the New York Stock Exchange (NYSE) under the ticker symbol "EQC."

Who are Equity Commonwealth's major shareholders?

Equity Commonwealth's stock is owned by a variety of institutional and retail investors. Top institutional investors include Ariel Investments LLC (6.35%), Segall Bryant & Hamill LLC (4.25%), Chai Trust Co. LLC (3.07%), State Street Corp (3.06%), Burgundy Asset Management Ltd. (2.49%) and Geode Capital Management LLC (2.10%).
View institutional ownership trends
.

How do I buy shares of Equity Commonwealth?

Shares of EQC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Equity Commonwealth's stock price today?

One share of EQC stock can currently be purchased for approximately $18.52.

How much money does Equity Commonwealth make?

Equity Commonwealth (NYSE:EQC) has a market capitalization of $2.03 billion and generates $63.14 million in revenue each year. The real estate investment trust earns $37.26 million in net income (profit) each year or $0.57 on an earnings per share basis.

How can I contact Equity Commonwealth?

Equity Commonwealth's mailing address is TWO NORTH RIVERSIDE PLAZA SUITE 2100, CHICAGO IL, 60606. The official website for the company is www.eqcre.com. The real estate investment trust can be reached via phone at (312) 646-2800, via email at ir@eqcre.com, or via fax at 617-796-8376.

This page (NYSE:EQC) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -